VIVO
Meridian Bioscience Inc
VIVO
VIVO
Delisted
VIVO was delisted on the 30th of January, 2023.
170 hedge funds and large institutions have $363M invested in Meridian Bioscience Inc in 2019 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 63 increasing their positions, 50 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
170
Holders Change
+7
Holders Change %
+4.29%
% of All Funds
3.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
63
Reduced
50
Closed
19
Calls
$139K
Puts
$170K
Net Calls
-$31K
Net Calls Change
-$313K
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.01M |
| 2 |
BlackRock
New York
|
+$3.53M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.62M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$2.3M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$2.09M |
Top Sellers
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$23.7M |
| 2 |
PP
Prudential plc
London, England,
United Kingdom
|
-$8.13M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$4.27M |
| 4 |
JPMorgan Chase & Co
New York
|
-$4.21M |
| 5 |
Goldman Sachs
New York
|
-$3.43M |
